Get started
Pfizer Inc Shs Cert Deposito Arg Repr 0.25 ShsPfizer Inc Shs Cert Deposito Arg Repr 0.25 ShsPfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs

Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

PFE trade ideas

Pfizer’s Next Big Shot: COVID Levels Back on the Table?Huge Crisis or Groundbreaking Discovery? This scenario suggests that once the running flat correction is completed — which we are very close to — the price is set to explode by at least 300% in the coming years (see red box). Why do I think so? • The running correction is approaching its final target zone, meaning the price should soon stop, reverse, and start pumping. • After the correction phase comes the impulse, and we are expecting Wave 3 — the most volatile and dynamic wave of all. • Minimum target: $108 It’s only a matter of sooner or later.
NYSE:PFELong
by Jossim_Elliott
1
PFE is forming a trough no questions asked! 3Ms is so oversold !Using only the Money flow index is dangerous game do your own analysis!... The Money Flow Index (MFI) is a technical indicator that uses price and volume to identify overbought or oversold conditions in a security, similar to the Relative Strength Index (RSI) but incorporating volume data. It's a momentum oscillator ranging from 0 to 100, with readings above 80 often suggesting an overbought market (potential sell signal) and readings below 20 indicating an oversold market (potential buy signal). Traders use the MFI to confirm price trends, identify divergences (warnings of trend reversals), and gauge investor conviction behind price moves
NYSE:PFELong
by samitrading
Pfizer's Weekly Supply Rejection Points to Possible TriggerPfizer Inc. recently retested a significant weekly supply zone, experiencing a rejection that suggests the market may revisit this level again. This retest could serve as a setup for a potential decline toward the daily demand area. Additionally, seasonal analysis indicates that the stock may continue its bearish trend, supporting the possibility of further downside movement. Traders should monitor these technical levels and seasonal signals for potential trading opportunities aligned with the ongoing bearish outlook. ✅ Please share your thoughts about PFE in the comments section below and HIT LIKE if you appreciate my analysis. Don't forget to FOLLOW ME; you will help us a lot with this small contribution.
NYSE:PFEShort
by FOREXN1
3
Pfizer May Be StallingPfizer has limped higher since April, but some traders may think the pharmaceutical giant is at risk of stalling. The first pattern on today’s chart is the series of lower highs since January. PFE potentially just made another lower high at this falling trendline, which may suggest resistance is taking effect. Second, the peak is occurring near the 200-day simple moving average. That could indicate its long-term trend is pointing lower. Third is the 2023 low of $25.76. At the time, it was the lowest price in the preceding decade. After spending more than a year on either side of this level, PFE is now stalling in the same area. Has old support finally turned into new resistance? Fourth, the candles of July 8 and July 10 showed prices trying and failing to cross the same long-term level. Such “shooting star” candlesticks may be short-term reversal patterns. Finally, PFE is an active underlier in the options market. (It’s averaged more than 90,000 contracts per session in the last month, according to TradeStation data.) That might help traders take positions with calls and puts. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options and futures. If you're born to trade, we could be for you. See our Overview for more. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options or futures); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. View the document titled Characteristics and Risks of Standardized Options at www.TradeStation.com . Before trading any asset class, customers must read the relevant risk disclosure statements on www.TradeStation.com . System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors. Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission and a futures commission merchant licensed with the Commodity Futures Trading Commission). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association, and a number of exchanges. Options trading is not suitable for all investors. Your TradeStation Securities’ account application to trade options will be considered and approved or disapproved based on all relevant factors, including your trading experience. See www.TradeStation.com . Visit www.TradeStation.com for full details on the costs and fees associated with options. Margin trading involves risks, and it is important that you fully understand those risks before trading on margin. The Margin Disclosure Statement outlines many of those risks, including that you can lose more funds than you deposit in your margin account; your brokerage firm can force the sale of securities in your account; your brokerage firm can sell your securities without contacting you; and you are not entitled to an extension of time on a margin call. Review the Margin Disclosure Statement at www.TradeStation.com . TradeStation Securities, Inc. and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., both operating, and providing products and services, under the TradeStation brand and trademark. When applying for, or purchasing, accounts, subscriptions, products and services, it is important that you know which company you will be dealing with. Visit www.TradeStation.com for further important information explaining what this means.
NYSE:PFE
by TradeStation
PFIZER INC. (NYSE)For all vaccine enthusiasts, Pfizer shares are currently among the best options. At the time of publication, the price is holding steady at $24.83 . Our forecast is that the price will rise to $27.48 (minimum)! Most likely by August. Personally, I don't trade stocks, as I have decided to change my market preference, but I can say that if I were Warren Buffett , I would recommend buying it. ✅ The price is low. ✅ The brand is well-known. ✅ Pharmaceuticals is a profitable sector of the economy, on par with IT and other new technologies.
NYSE:PFELong
by Broenberg
1
BUY Pfizer (PFE) growth by Viagra Tomorrow, I’m entering a position in Pfizer Inc. (NYSE: PFE)—a globally recognized pharmaceutical giant with strong fundamentals and an attractive technical setup. Pfizer maintains a solid revenue base, reporting $62.46 billion in total revenue in the last fiscal year. Despite recent fluctuations, its profitability remains intact, with a gross profit of $45.15 billion. The company continues to invest in drug innovation and strategic acquisitions, ensuring long-term growth. Pfizer is a consistent dividend payer, making it an attractive choice for income-focused investors. Its dividend yield remains competitive, reinforcing its appeal as a long-term hold. I see strong upside potential — both technically and fundamentally. Now is the perfect time to enter.
NYSE:PFE
by Broceta
PFE - A GOOD DIVIDEND PLAY LONG TERMGood Morning, I have been keeping an eye on PFE for awhile as I want to get it on a low to hold in my TFSA long term for dividend payments. PFE created an initial support at level 21-21.50$. PFE continued to climb aggressively until seeing some rejection at the 24$ level. It dropped down to retest previous supports at the 21.50$ in which there was two good buying accumulation supports. From here I will be adding PFE to my TFSA for long term. For swing trade opportunity you could look to hold for 26.50$. ENJOY!
NYSE:PFELong
by mindfullylost
PFE – Long Trade Setup !📈 🟢 Ticker: Pfizer, Inc. (NYSE: PFE) Chart: 30-Min Timeframe Pattern: Ascending triangle breakout continuation 🔹 Entry: $24.38 (breakout from consolidation + trendline support) 🔹 Stop-Loss: $24.01 (below ascending trendline) 🔹 Take Profits:   TP1: $24.89 – Gap-fill resistance zone   TP2: $25.55 – Measured breakout target ⚖️ Risk-Reward Calculation: – Risk/Share: $0.37 – Reward to TP2: $1.17 – R:R Ratio: ~1:3.1 ✅ 🧠 Technical Highlights: – Clean breakout from ascending triangle pattern – Strong move with steady volume support – Price reclaiming key resistance with bullish follow-through
NYSE:PFELong
by ProfittoPath
Pfizer Stock Chart Fibonacci Analysis 042925Trading Idea 1) Find a FIBO slingshot 2) Check FIBO 61.80% level 3) Entry Point > 22.7/61.80% Chart time frame:D A) 15 min(1W-3M) B) 1 hr(3M-6M) C) 4 hr(6M-1year) D) 1 day(1-3years) Stock progress: C A) Keep rising over 61.80% resistance B) 61.80% resistance C) 61.80% support D) Hit the bottom E) Hit the top Stocks rise as they rise from support and fall from resistance. Our goal is to find a low support point and enter. It can be referred to as buying at the pullback point. The pullback point can be found with a Fibonacci extension of 61.80%. This is a step to find entry level. 1) Find a triangle (Fibonacci Speed Fan Line) that connects the high (resistance) and low (support) points of the stock in progress, where it is continuously expressed as a Slingshot, 2) and create a Fibonacci extension level for the first rising wave from the start point of slingshot pattern. When the current price goes over 61.80% level , that can be a good entry point, especially if the SMA 100 and 200 curves are gathered together at 61.80%, it is a very good entry point. As a great help, tradingview provides these Fibonacci speed fan lines and extension levels with ease. So if you use the Fibonacci fan line, the extension level, and the SMA 100/200 curve well, you can find an entry point for the stock market. At least you have to enter at this low point to avoid trading failure, and if you are skilled at entering this low point, with fibonacci6180 technique, your reading skill to chart will be greatly improved. If you want to do day trading, please set the time frame to 5 minutes or 15 minutes, and you will see many of the low point of rising stocks. If want to prefer long term range trading, you can set the time frame to 1 hr or 1 day.
NYSE:PFE
by fibonacci6180
Tensions in the Pharma Sector and Signs of U.S. StagflationBy Ion Jauregui – Analyst at ActivTrades The U.S. biopharmaceutical industry may soon face significant regulatory changes. According to sector sources, the Trump administration is evaluating a proposal to tie U.S. drug prices to the lowest prices available in other developed countries. This initiative, viewed by companies such as Pfizer Inc. (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK) as a direct threat to innovation, could redefine the global balance of the pharmaceutical sector. Macroeconomic Outlook: Stagflation Warning On the macroeconomic front, Citigroup Inc. (NYSE: C) has warned that despite current signs of consumer activity, the negative effects on growth are expected to intensify in the second half of the year. Nathan Sheets, the bank’s Chief Economist, points to rising risks of stagflation, in a context marked by declining confidence and renewed criticism from Donald Trump towards Federal Reserve Chair Jerome Powell. Defense Sector: Tariff Impact Raytheon Technologies (NYSE: RTX) has stated that new tariffs proposed by the Trump administration could have a negative impact of up to $850 million on its 2025 earnings. Nevertheless, the company exceeded market expectations in its latest quarterly results and reaffirmed its annual guidance. Shareholder Reshuffle at BP Activist fund Elliott has acquired a 5.006% stake in BP plc (LON: BP), surpassing the regulatory threshold in the United Kingdom and becoming the company’s second-largest shareholder—behind BlackRock (9.2%) and ahead of Vanguard (4.95%). This strategic move reflects the increasing shareholder pressure on major oil companies. Key Events of the Day Notable economic indicators and corporate earnings scheduled for today include: • S&P Global Manufacturing PMI • S&P Global Services PMI • Earnings reports from: Philip Morris (PM), IBM (IBM), AT&T (T), Thermo Fisher Scientific (TMO), ServiceNow Inc. (NOW), Boston Scientific (BSX), Texas Instruments (TXN), Boeing (BA), O’Reilly Automotive (ORLY), Chipotle Mexican Grill (CMG) These releases are expected to have a significant impact on markets, particularly across the consumer, technology, and defense sectors. ******************************************************************************************* The information provided does not constitute investment research. The material has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and such should be considered a marketing communication. All information has been prepared by ActivTrades ("AT"). The information does not contain a record of AT's prices, or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. Any material provided does not have regard to the specific investment objective and financial situation of any person who may receive it. Past performance is not reliable indicator of future performance. AT provides an execution-only service. Consequently, any person acting on the information provided does so at their own risk.
NYSE:PFEShort
by ActivTrades